| abstract |
The invention relates to a medicament containing a compound of general formula (1), where n n nR 1 =independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C 11 -C 21 alkyl, alkylene or alkinyl group, preferably a C 11 -C 15 alkyl, alkylene or alkinyl group, particularly a C 11 -C 13 alkyl, alkylene or alkinyl group, most preferably a C 13 alkyl group, R2=independently, a straight or branched C 1 -C 8 alkyl, alkylene or alkinyl group, preferably a C 1 -C 6 alkyl, alkylene or alkinyl group, in particular a C 2 -C 4 alkyl, alkylene or alkinyl group, most preferably a C 3 alkyl group, a —[CH 2 —(CH 2 ) m —O] n H group with n=1 to 10, preferably n=1 to 5, m==1 to 5, preferably m=1 to 3, a —CH 2 —[CH—(OH)] p [CH 2 -(R 3 )]— group, where R 3 =independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tumour diseases, in particular caused by human papilloma virus (HPV) and/or herpes viruses and a topically acting medicament formulation and the use thereof. |